Weber, Romeo, Dolley-Sonneville. Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor. Corning Incorporated, Life Sciences, Corning, NY USA
Princeman, Tilakawardane, Jeang, Aguilar, Murad, Park, Chang, Ostberg, Neman, Jandial, Portnow, Forman, Brown. Regional Delivery of Chimeric Antigen Receptor– Engineered T Cells Effectively Targets HER2þ Breast Cancer Metastasis to the Brain. Clin Cancer Res. 2017 Oct 23. doi: 10.1158/1078-0432.CCR-17-2041
Lim R, Hodge A, Moore G, Wallace E, Slevert W. A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis. Front. Pharmacol. 8:549.doi: 10.3389/fphar.2017.00549
Fink J, Abazari A, Hawkins B, Albert M, O’Donnell K, Mathew A. Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C. Biopreservation and Biobanking Volume 15, Number 3, 2017. DOI:10.1089=bio.2017.29021.abstracts
Transition to GMP, chemically-defined, xeno-free cryopreservation media increases post-thaw functionality of clinically relevant cell banks
Cryopreservation and Transport of Jurkat T Cells Using Current and Optimized Practices: The Impact of Temperature and Length of Storage
Gardner R, Finney O, Annesley C, Brakke H, Summers C, Leger K, Bleakley M, Brown C, Mgebroff S, Spratt K, Hoglund V, Lindgren C, Oron A, Li D, Riddell S, Park J, Jensen M. Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults. Blood 2017 :blood-2017-02-769208. doi:…
Brown C, Alizadeh D, Starr R, Weng L, Wagner J, et al. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. N Engl J Med 2016;375:2561-9 DOI: 10.1056/NEJMoa1610497
Aliota M, Dudley D, Newman C, Mohr E, et al. Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques. PLoS Negl Trop Dis 10(12): e0005168 DOI:10.1371/journal.pntd.0005168
DiGiusto D, Canno P, Holmes M, Li L, et al. Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells. Molecular Therapy — Methods & Clinical Development 3, Article number: 16067 (2016) doi:10.1038/mtm.2016.67
